SEARCH NEWS & VIEWS


Team Finds New Calorie-Burning Switch in Brown Fat
Scientists Create Most Detailed Map Yet of Virus that Causes Colds, Pink Eye
Researchers Find Genetic Mutations Linked to Salivary Gland Tumors
TSRI Scientists Awarded $3.4 Million to Investigate the Secret Lives of Brain Cells
NEWS & VIEWS HOME
PAST ISSUES
KUDOS
SCIENTIFIC CALENDAR
CA AUDITORIUM EVENTS
CONTACT

FOLLOW US

Of Note


David Gokhin Wins NIH Pathway to Independence Award

David Gokhin, senior research associate in the Fowler laboratory at TSRI, has received an National Institutes of Health (NIH) Pathway to Independence Award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases. This five-year award supports promising postdoctoral researchers as they transition to faculty positions.

Gokhin’s project, “Structure and Remodeling of the Distal Segment of the Thin Filament,” focuses on the application of novel imaging tools to study the molecular mechanisms involved in the specification of actin filament length in skeletal muscle sarcomeres. The goal of the research is to help lay the foundation for therapies for congenital diseases such as nemaline myopathy and Duchenne muscular dystrophy.


Joel Blanchard Receives Stem Cell Research Poster Award

Joel Blanchard, graduate student in the Baldwin lab, recently received the 2014 Betty Jean Ogawa Memorial Poster Award at the annual meeting of the International Society for Stem Cell Research (ISSCR), a cross-disciplinary organization with more than 4,100 members dedicated to stem cell research.

One of six winners selected from 700 eligible posters, Blanchard’s poster was titled “Deprogramming, Reprogramming: Uncovering Mechanisms and Inducers of Pluripotency via Combinatorial Antibody Screening.” As part of the award, he will attend the 2015 ISSCR annual meeting in Stockholm next June.

Blanchard’s research, a collaboration with the Lerner lab, seeks to develop methods to convert (or reprogram) ordinary skin cells into embryonic stem cells solely using antibodies that act at the cell surface. The goal of the project is to better understand the biology of reprogramming and develop safer modes for generating patient-specific stem cells for use in transplantation therapies.





Send comments to: mikaono[at]scripps.edu